Read More Pharma Industry News BITT secures NIH funding for pioneering Sjögren’s syndrome treatment Boston Immune Technologies and Therapeutics, Inc. (BITT), a leading clinical-stage biotechnology firm specializing in tumor necrosis factor superfamily… byPallavi MadhirajuSeptember 3, 2023